Stock listing
RNAZ Stock Price, News, Filings & Events — Transcode Therapeutics, Inc.
Selected listing: RNAZ · NASDAQ · USD · US
RNAZ:NASDAQ is the public listing for Transcode Therapeutics, Inc., a biotechnology company based in the United States. The company is dedicated to developing innovative therapeutic solutions and is actively advancing its research and development initiatives. With a market capitalization of around $6.28 million, Transcode Therapeutics focuses on addressing significant medical needs through its proprietary technologies. Recent news and filings may provide further insights into the company's progress and strategic direction.
- Ticker
- RNAZ:NASDAQ
- Asset type
- Stock
- Market cap
- $6.3M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Transcode Therapeutics, Inc. RNAZ:NASDAQ stock context
RNAZ:NASDAQ is the public listing for Transcode Therapeutics, Inc., a biotechnology company based in the United States. The company is dedicated to developing innovative therapeutic solutions and is actively advancing its research and development initiatives. With a market capitalization of around $6.28 million, Transcode Therapeutics focuses on addressing significant medical needs through its proprietary technologies. Recent news and filings may provide further insights into the company's progress and strategic direction.
Research Transcode Therapeutics, Inc.
Transcode Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for RNAZ:NASDAQ.
Transcode Therapeutics, Inc. company profile
View the public company page for Transcode Therapeutics, Inc. on 6ix.
Transcode Therapeutics, Inc. news
Read company news and market updates connected to Transcode Therapeutics, Inc..
Transcode Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Transcode Therapeutics, Inc..